These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 9038263

  • 1. Overexpression of cyclin D1 in epithelial ovarian cancers.
    Worsley SD, Ponder BA, Davies BR.
    Gynecol Oncol; 1997 Feb; 64(2):189-95. PubMed ID: 9038263
    [Abstract] [Full Text] [Related]

  • 2. Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma.
    Zhang YJ, Jiang W, Chen CJ, Lee CS, Kahn SM, Santella RM, Weinstein IB.
    Biochem Biophys Res Commun; 1993 Oct 29; 196(2):1010-6. PubMed ID: 8240318
    [Abstract] [Full Text] [Related]

  • 3. Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene.
    Zukerberg LR, Yang WI, Gadd M, Thor AD, Koerner FC, Schmidt EV, Arnold A.
    Mod Pathol; 1995 Jun 29; 8(5):560-7. PubMed ID: 7675778
    [Abstract] [Full Text] [Related]

  • 4. Overexpression of cyclin D1 enhances gene amplification.
    Zhou P, Jiang W, Weghorst CM, Weinstein IB.
    Cancer Res; 1996 Jan 01; 56(1):36-9. PubMed ID: 8548770
    [Abstract] [Full Text] [Related]

  • 5. Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer.
    Naitoh H, Shibata J, Kawaguchi A, Kodama M, Hattori T.
    Am J Pathol; 1995 May 01; 146(5):1161-9. PubMed ID: 7747810
    [Abstract] [Full Text] [Related]

  • 6. Cyclin gene amplification and overexpression in breast and ovarian cancers: evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors.
    Courjal F, Louason G, Speiser P, Katsaros D, Zeillinger R, Theillet C.
    Int J Cancer; 1996 Aug 22; 69(4):247-53. PubMed ID: 8797862
    [Abstract] [Full Text] [Related]

  • 7. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
    Shao HL, Shen DH, Xue WC, Li Y, Yu YZ.
    Zhonghua Fu Chan Ke Za Zhi; 2007 Apr 22; 42(4):227-32. PubMed ID: 17631760
    [Abstract] [Full Text] [Related]

  • 8. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining.
    Gillett C, Fantl V, Smith R, Fisher C, Bartek J, Dickson C, Barnes D, Peters G.
    Cancer Res; 1994 Apr 01; 54(7):1812-7. PubMed ID: 8137296
    [Abstract] [Full Text] [Related]

  • 9. Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer.
    Bali A, O'Brien PM, Edwards LS, Sutherland RL, Hacker NF, Henshall SM.
    Clin Cancer Res; 2004 Aug 01; 10(15):5168-77. PubMed ID: 15297421
    [Abstract] [Full Text] [Related]

  • 10. Stable overexpression of cyclin D1 in a human mammary epithelial cell line prolongs the S-phase and inhibits growth.
    Han EK, Sgambato A, Jiang W, Zhang YJ, Santella RM, Doki Y, Cacace AM, Schieren I, Weinstein IB.
    Oncogene; 1995 Mar 02; 10(5):953-61. PubMed ID: 7898937
    [Abstract] [Full Text] [Related]

  • 11. [Invasive ductal carcinoma of the breast: study of the number of copies of the CCND1 gene and chromosome 11 using fluorescence in situ hybridization (FISH) in comparison with expression of cyclin D1 protein and estrogen receptors (ER alpha) with immunohistochemical detection].
    Mrhalová M, Kodet R, Strnad P.
    Cas Lek Cesk; 2002 Nov 08; 141(22):708-14. PubMed ID: 12532908
    [Abstract] [Full Text] [Related]

  • 12. Deregulation of D-type cyclins in uterine cancers. Cyclin D1/D3 is differentially expressed in cervical cancer.
    Skomedal H, Forus A, Holm R.
    Anticancer Res; 2003 Nov 08; 23(5A):3929-35. PubMed ID: 14666699
    [Abstract] [Full Text] [Related]

  • 13. Oral contraceptive use and cyclin D1 overexpression in breast cancer among young women.
    Terry MB, Gammon MD, Schoenberg JB, Brinton LA, Arber N, Hibshoosh H.
    Cancer Epidemiol Biomarkers Prev; 2002 Oct 08; 11(10 Pt 1):1100-3. PubMed ID: 12376514
    [Abstract] [Full Text] [Related]

  • 14. Oncogene amplification and overexpression of oncoproteins in thyroid papillary cancer.
    Várkondi E, Gyory F, Nagy A, Kiss I, Ember I, Kozma L.
    In Vivo; 2005 Oct 08; 19(2):465-70. PubMed ID: 15796211
    [Abstract] [Full Text] [Related]

  • 15. Determination of the prognostic value of cyclin D1 overexpression in breast cancer.
    McIntosh GG, Anderson JJ, Milton I, Steward M, Parr AH, Thomas MD, Henry JA, Angus B, Lennard TW, Horne CH.
    Oncogene; 1995 Sep 07; 11(5):885-91. PubMed ID: 7675447
    [Abstract] [Full Text] [Related]

  • 16. A truncated cyclin D1 gene encodes a stable mRNA in a human breast cancer cell line.
    Lebwohl DE, Muise-Helmericks R, Sepp-Lorenzino L, Serve S, Timaul M, Bol R, Borgen P, Rosen N.
    Oncogene; 1994 Jul 07; 9(7):1925-9. PubMed ID: 8208539
    [Abstract] [Full Text] [Related]

  • 17. EMS1 gene expression in primary breast cancer: relationship to cyclin D1 and oestrogen receptor expression and patient survival.
    Hui R, Ball JR, Macmillan RD, Kenny FS, Prall OW, Campbell DH, Cornish AL, McClelland RA, Daly RJ, Forbes JF, Blamey RW, Musgrove EA, Robertson JF, Nicholson RI, Sutherland RL.
    Oncogene; 1998 Aug 27; 17(8):1053-9. PubMed ID: 9747885
    [Abstract] [Full Text] [Related]

  • 18. Antisense oligodeoxynucleotides targeted against different regions of cyclin D1 mRNA may exert different inhibitory effects on cell growth and gene expression.
    Hung WC, Huang JS, Chuang LY.
    Biochem Biophys Res Commun; 1996 Mar 27; 220(3):719-23. PubMed ID: 8607831
    [Abstract] [Full Text] [Related]

  • 19. Estrogen-induced cyclin D1 and D3 gene expressions during mouse uterine cell proliferation in vivo: differential induction mechanism of cyclin D1 and D3.
    Geum D, Sun W, Paik SK, Lee CC, Kim K.
    Mol Reprod Dev; 1997 Apr 27; 46(4):450-8. PubMed ID: 9094091
    [Abstract] [Full Text] [Related]

  • 20. Amplification and overexpression of EXP1 and EXP2/Cyclin D1 genes in human esophageal carcinomas.
    Tsuruta H, Sakamoto H, Onda M, Terada M.
    Biochem Biophys Res Commun; 1993 Nov 15; 196(3):1529-36. PubMed ID: 8250909
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.